Literature DB >> 23159117

Histopathological features of bisphosphonate-associated osteonecrosis: findings in patients treated with partial mandibulectomies.

Young-Ah Cho1, Hye-Jung Yoon, Jae-Il Lee, Sam-Pyo Hong, Seong-Doo Hong.   

Abstract

The present study investigated the histopathologic and radiographic features of stage 3 bisphosphonate-associated osteonecrosis of the jaw (BAONJ) in patients who were treated with partial mandibulectomies. Bisphosphonates had been orally administered to 10 patients with osteoporosis and intravenously administered to 1 patient with metastatic carcinoma. On radiographic images, massive osteolysis and periosteal bone formations were conspicuous, and a thin mandibular cortical width was observed in 5 of 10 osteoporosis patients despite the previous use of bisphosphonate. Microscopically, the mandibulectomy specimens of the patients could be divided into 4 distinct layers. Although there were few differences in overall histologic features between BAONJ and chronic suppurative osteomyelitis, a notable number of osteoclasts were found detached from the bony trabeculae in BAONJ.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159117     DOI: 10.1016/j.oooo.2012.08.457

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  7 in total

1.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

2.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

3.  Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.

Authors:  D Yoshiga; M Sasaguri; K Matsuo; S Kokuryou; M Habu; M Oda; M Kodama; H Tsurushima; O Sakaguchi; T Sakurai; J Tanaka; Y Morimoto; I Yoshioka; K Tominaga
Journal:  Osteoporos Int       Date:  2015-06-03       Impact factor: 4.507

4.  Stage 0 osteonecrosis of the jaw in a patient on denosumab.

Authors:  Tara L Aghaloo; Sarah M Dry; Sanjay Mallya; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2014-01-04       Impact factor: 1.895

5.  Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: Pathological features of two cases.

Authors:  Yuki Matsushita; Saki Hayashida; Kota Morishita; Hiroshi Sakamoto; Tomofumi Naruse; Yuki Sakamoto; Shin-Ichi Yamada; Souichi Yanamoto; Shuichi Fujita; Tohru Ikeda; Masahiro Umeda
Journal:  Mol Clin Oncol       Date:  2015-12-07

6.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

7.  Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.

Authors:  Shinichiro Kuroshima; Kazunori Nakajima; Muneteru Sasaki; Takashi I; Yoshinori Sumita; Takayuki Asahara; Izumi Asahina; Takashi Sawase
Journal:  Stem Cell Res Ther       Date:  2019-07-16       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.